Annual Working Capital
$146.08 M
-$32.54 M-18.22%
31 December 2023
Summary:
Compass Therapeutics annual working capital is currently $146.08 million, with the most recent change of -$32.54 million (-18.22%) on 31 December 2023. During the last 3 years, it has risen by +$105.98 million (+264.26%). CMPX annual working capital is now -18.22% below its all-time high of $178.62 million, reached on 31 December 2022.CMPX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$136.71 M
-$7.33 M-5.09%
01 September 2024
Summary:
Compass Therapeutics quarterly working capital is currently $136.71 million, with the most recent change of -$7.33 million (-5.09%) on 01 September 2024. Over the past year, it has dropped by -$20.75 million (-13.18%). CMPX quarterly working capital is now -23.47% below its all-time high of $178.62 million, reached on 31 December 2022.CMPX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.2% | -13.2% |
| 3 y3 years | +264.3% | +554.4% |
| 5 y5 years | +189.8% | - |
CMPX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.2% | +264.3% | -23.5% | +554.4% |
| 5 y | 5 years | -18.2% | +789.8% | -23.5% | +732.7% |
| alltime | all time | -18.2% | +789.8% | -23.5% | +732.7% |
Compass Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $136.71 M(-5.1%) |
| June 2024 | - | $144.04 M(-6.9%) |
| Mar 2024 | - | $154.72 M(+5.9%) |
| Dec 2023 | $146.08 M(-18.2%) | $146.08 M(-7.2%) |
| Sept 2023 | - | $157.46 M(-4.9%) |
| June 2023 | - | $165.57 M(-4.0%) |
| Mar 2023 | - | $172.41 M(-3.5%) |
| Dec 2022 | $178.62 M | $178.62 M(+58.1%) |
| Sept 2022 | - | $112.98 M(-8.6%) |
| June 2022 | - | $123.66 M(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $130.95 M(-4.0%) |
| Dec 2021 | $136.47 M(+240.3%) | - |
| Dec 2021 | - | $136.47 M(+553.3%) |
| Sept 2021 | - | $20.89 M(-20.1%) |
| June 2021 | - | $26.14 M(-15.1%) |
| Mar 2021 | - | $30.80 M(-23.2%) |
| Dec 2020 | $40.10 M(+144.3%) | $40.10 M(-16.7%) |
| Sept 2020 | - | $48.16 M(-13.5%) |
| June 2020 | - | $55.68 M(+239.2%) |
| Dec 2019 | $16.42 M(-67.4%) | $16.42 M |
| Dec 2018 | $50.42 M | - |
FAQ
- What is Compass Therapeutics annual working capital?
- What is the all time high annual working capital for Compass Therapeutics?
- What is Compass Therapeutics annual working capital year-on-year change?
- What is Compass Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Compass Therapeutics?
- What is Compass Therapeutics quarterly working capital year-on-year change?
What is Compass Therapeutics annual working capital?
The current annual working capital of CMPX is $146.08 M
What is the all time high annual working capital for Compass Therapeutics?
Compass Therapeutics all-time high annual working capital is $178.62 M
What is Compass Therapeutics annual working capital year-on-year change?
Over the past year, CMPX annual working capital has changed by -$32.54 M (-18.22%)
What is Compass Therapeutics quarterly working capital?
The current quarterly working capital of CMPX is $136.71 M
What is the all time high quarterly working capital for Compass Therapeutics?
Compass Therapeutics all-time high quarterly working capital is $178.62 M
What is Compass Therapeutics quarterly working capital year-on-year change?
Over the past year, CMPX quarterly working capital has changed by -$20.75 M (-13.18%)